# Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

> **NCT06577077** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ache Laboratorios Farmaceuticos S.A.** · enrollment: 432 (estimated)

## Conditions studied

- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** Product CM9241GRU
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06577077
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 432 (ESTIMATED)
- **Last updated:** 2024-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06577077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06577077, "Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06577077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*